Zahi Fayad

Person

A researcher at Mount Sinai in New York who ran the Initial trial, looking at arterial wall inflammation using fluorodeoxyglucose.

Mentioned in 1 video

Videos Mentioning Zahi Fayad

210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.

210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.

Peter Attia MD

A researcher at Mount Sinai in New York who ran the Initial trial, looking at arterial wall inflammation using fluorodeoxyglucose.